Market Research Consumer Goods Market Research Consumer Goods & Retailing Market Research Pet Services & Supplies Market Research Pet Care Services Market Research

Canine Arthritis Treatment Market - Global Industry Analysis and Opportunity Assessment, 2019-2029

Best Price Guarantee Length Publisher Published Date SKU
from $5,000 183 Pages Future Market Insights October, 2019 FMARI16090455
Best Price Guarantee
Price from $5,000
Length 183 Pages
Publisher Future Market Insights
Published Date October, 2019
SKU FMARI16090455

Canine Arthritis Treatment Market - Global Industry Analysis and Opportunity Assessment, 2019-2029

A recent market study published by Future Market Insights (FMI) on the canine arthritis treatment including global industry analysis 2014-2018 & opportunity assessment 2019-2029, delivers a comprehensive assessment of the most important market dynamics. After conducting a thorough research on the historical as well as current growth parameters of the canine arthritis treatment, the growth prospects of the market are obtained with maximum precision.

Chapter 01 – Executive Summary

The report initiates with the executive summary of the canine arthritis treatment, which includes a summary of key findings and statistics of the market. It also includes market size and revenue distribution of market segment of the canine arthritis treatment.

Chapter 02 – Market Overview

Readers can find the definition and a detailed segmentation of the canine arthritis treatment in this chapter, which will help them understand the basic information about the canine arthritis treatment.

Chapter 03 – Market Background

This chapter explains the key macroeconomic factors, drivers, restraints, trends and opportunity analysis that are expected to influence the growth of the canine arthritis treatment over the forecast period. Moreover, in-depth information about the market dynamics and their impact analysis on the market have been provided in the successive section.

Chapter 04 – Market Context

This section includes premium insights such as regulatory scenario, disease epidemiology, industry view point and market evolution. This section helps readers understand the key factors associated with the canine arthritis treatment market.

Chapter 05 – Global Canine Arthritis Treatment Value Analysis 2014-2018 & Opportunity Assessment 2019-2029

This section explains the global market value analysis and forecast for the Canine Arthritis treatment between the forecast periods of 2019-2029. This chapter includes a detailed analysis of the historical canine arthritis treatment market, along with an opportunity analysis of the future. Readers can also find the absolute $ opportunity for the current year (2019), and an incremental $ opportunity for the forecast period (2019–2029).

Chapter 06 – Global Canine Arthritis Treatment Analysis 2014-2018 & Opportunity Assessment 2019-2029, by Treatment

Based on treatment type, the canine arthritis treatment market is segmented into Non-steroidal anti-inflammatory medications (NSAIDs), opioids and stem cell therapy. In this chapter, readers can find information about the key trends and developments in the canine arthritis treatment and market attractiveness analysis based on treatment.

Chapter 07 – Global Canine Arthritis Treatment Analysis 2014-2018 & Opportunity Assessment 2019-2029, by Route of Administration

This chapter provides details about the canine arthritis treatment based on mode of administration, and has been classified into oral and injectable. In this chapter, readers can understand the market attractiveness analysis based on route of administration.

Chapter 08 – Global Canine Arthritis Treatment Analysis 2014-2018 & Opportunity Assessment 2019-2029, by Distribution Channel

This chapter provides details about the canine arthritis treatment market based on distribution channel, and has been classified into veterinary hospitals and clinics, retail pharmacies, drug stores, and E-Commerce. In this chapter, readers can understand the market attractiveness analysis based on distribution channel.

Chapter 09 – Global Canine Arthritis Treatment Analysis 2014-2018 & Opportunity Assessment 2019-2029, by Region

This chapter explains how the canine arthritis treatment market will grow across various geographic regions such as North America, Latin America, Europe, Asia-Pacific excluding Japan, Japan, and Middle East & Africa (MEA).

Chapter 10 – North America Canine Arthritis Treatment Analysis 2014-2018 & Opportunity Assessment 2019-2029

This chapter includes a detailed analysis of the growth of the North America canine arthritis treatment market, along with a country-wise assessment that includes the U.S. and Canada. Readers can also find the pricing analysis, regional trends, and market growth based on the application and countries in North America.

Chapter 11 – Latin America Canine Arthritis Treatment Analysis 2014-2018 & Opportunity Assessment 2019-2029

This chapter provides the growth scenario of the canine arthritis treatment market in Latin American countries such as Brazil, Mexico, and the Rest of Latin America. Along with this, assessment of the market across target segments has been provided.

Chapter 12 – Europe Canine Arthritis Treatment Analysis 2014-2018 & Opportunity Assessment 2019-2029

Important growth prospects of the canine arthritis treatment market based on its Distribution Channels in several countries such as Germany, the U.K., France, Spain, Italy, Russia, and the Rest of Europe are included in this chapter.

Chapter 13 – Asia Pacific Excluding Japan Canine Arthritis Treatment Analysis 2014-2018 & Opportunity Assessment 2019-2029

This chapter highlights the growth of the canine arthritis treatment in Asia pacific excluding Japan by focusing on China, India, Australia & New Zealand, ASEAN and rest of APEJ. This section also help readers understand the key factors that are responsible for the growth of the canine arthritis treatment market in the APEJ region.

Chapter 14 – Japan Canine Arthritis Treatment Analysis 2014-2018 & Opportunity Assessment 2019-2029

This chapter highlights the growth of the canine arthritis treatment in Japan. This section also help readers understand the key factors that are responsible for the growth of the canine arthritis treatment market in Japan.

Chapter 15 – MEA Canine Arthritis Treatment Analysis 2014-2018 & Opportunity Assessment 2019-2029

This chapter provides information about how the canine arthritis treatment market will grow in major countries in the MEA region such as GCC Countries, South Africa, and the Rest of MEA, during the forecast period of 2019-2029.

Chapter 16 – Competition Analysis

In this chapter, readers can find a comprehensive list of all the prominent stakeholders in the canine arthritis treatment market, along with a detailed information about each company, which includes company overview, revenue shares, strategic overview, and recent company developments. Some of the market players featured in the report are Elanco, Zoetis, Bayer, VetStem Biopharma and among others.

Chapter 17 – Assumptions and Acronyms

This chapter includes a list of acronyms and assumptions that provides a base to the information and statistics included in the canine arthritis treatment report.

Chapter 18 – Research Methodology

This chapter help readers understand the research methodology followed to obtain various conclusions as well as important qualitative and quantitative information about The Canine Arthritis Treatment.


1. Executive Summary
1.1. Market Outlook
1.2. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Macro-Economic Factors
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity Analysis
3.1.4. Trends
4. Market Context
4.1. Global Healthcare Market Outlook
4.2. Global Canine Arthritis Treatment Scenario
4.3. Pet Ownership in European Union (EU)
4.4. Share of Household Owing at least one Dog in European Union (EU)
4.5. Spending on Health of Pets
4.6. Vet care Spending on Dogs
4.7. Key Regulations and Guidelines
5. Global Canine Arthritis Treatment Market (in Value or Size in US$ Mn) Analysis 2014-2018 and Forecast, 2019-2029
5.1. Historical Market Value (US$ Mn) Analysis, 2014-2018
5.2. Current and Future Market Value (US$ Mn) Projections, 2019-2029
5.2.1. Y-o-Y Growth Trend Analysis
5.2.2. Absolute $ Opportunity Analysis
5.2.3. Market Value Comparison
6. Global Canine Arthritis Treatment Market Analysis 2014-2018 and Forecast 2019-2029, by Treatment Type
6.1. Introduction / Key Findings
6.2. Historical Market Size (US$ Mn) Analysis By Treatment Type, 2014-2018
6.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Treatment Type, 2019 - 2029
6.3.1. Non-steroidal anti-inflammatory Medications (NSAIDs)
6.3.2. Opioids
6.3.3. Stem Cell Therapy
6.3.3.1. Allogeneic Stem Cells
6.3.3.2. Autologous Stem Cells
6.4. Market Attractiveness Analysis By Treatment Type
7. Global Canine Arthritis Treatment Market Analysis 2014-2018 and Forecast 2019-2029, by Route of Administration
7.1. Introduction / Key Findings
7.2. Historical Market Size (US$ Mn) Analysis By Route of Administration, 2014-2018
7.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Route of Administration, 2019 - 2029
7.3.1. Oral
7.3.2. Injectable
7.4. Market Attractiveness Analysis By Route of Administration
8. Global Canine Arthritis Treatment Market Analysis 2014-2018 and Forecast 2019-2029, by Distribution Channel
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2014-2018
8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Distribution Channel, 2019 - 2029
8.3.1. Veterinary Hospital and Clinics
8.3.2. Retail Pharmacies
8.3.3. Drug Stores
8.3.4. E-Commerce
8.3.5. Market Attractiveness Analysis By Distribution Channel
9. Global Canine Arthritis Treatment Market Analysis 2014-2018 and Forecast 2019-2029, by Region
9.1. Introduction
9.2. Historical Market Size (US$ Mn) Analysis By Region, 2014-2018
9.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2019 - 2029
9.3.1. North America
9.3.2. Latin America
9.3.3. Europe
9.3.4. Asia-Pacific Excluding Japan
9.3.5. Japan
9.3.6. Middle East and Africa
9.4. Market Attractiveness Analysis By Region
10. North America Canine Arthritis Treatment Market Analysis 2014-2018 and Forecast 2019-2029
10.1. Introduction
10.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2018
10.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 - 2029
10.3.1. By Country
10.3.1.1. U.S.
10.3.1.2. Canada
10.3.2. By Treatment Type
10.3.3. By Route of Administration
10.3.4. By Distribution Channel
10.4. Market Attractiveness Analysis
10.4.1. By Country
10.4.2. By Treatment Type
10.4.3. By Route of Administration
10.4.4. By Distribution Channel
11. Latin America Canine Arthritis Treatment Market Analysis 2014-2018 and Forecast 2019-2029
11.1. Introduction
11.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2018
11.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 - 2029
11.3.1. By Country
11.3.1.1. Mexico
11.3.1.2. Brazil
11.3.1.3. Rest of Latin America
11.3.2. By Treatment Type
11.3.3. By Route of Administration
11.3.4. By Distribution Channel
11.4. Market Attractiveness Analysis
11.4.1. By Country
11.4.2. By Treatment Type
11.4.3. By Route of Administration
11.4.4. By Distribution Channel
12. Europe Canine Arthritis Treatment Market Analysis 2014-2018 and Forecast 2019-2029
12.1. Introduction
12.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2018
12.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 - 2029
12.3.1. By Country
12.3.1.1. Germany
12.3.1.2. Italy
12.3.1.3. France
12.3.1.4. U.K.
12.3.1.5. Spain
12.3.1.6. Russia
12.3.1.7. Rest of Europe
12.3.2. By Treatment Type
12.3.3. By Route of Administration
12.3.4. By Distribution Channel
12.4. Market Attractiveness Analysis
12.4.1. By Country
12.4.2. By Treatment Type
12.4.3. By Route of Administration
12.4.4. By Distribution Channel
13. APEJ Canine Arthritis Treatment Market Analysis 2014-2018 and Forecast 2019-2029
13.1. Introduction
13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2018
13.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 - 2029
13.3.1. By Country
13.3.1.1. China
13.3.1.2. India
13.3.1.3. Australia & New Zealand
13.3.1.4. ASEAN
13.3.1.5. Rest of APEJ
13.3.2. By Treatment Type
13.3.3. By Route of Administration
13.3.4. By Distribution Channel
13.4. Market Attractiveness Analysis
13.4.1. By Country
13.4.2. By Treatment Type
13.4.3. By Route of Administration
13.4.4. By Distribution Channel
14. Japan Canine Arthritis Treatment Market Analysis 2014-2018 and Forecast 2019-2029
14.1. Introduction
14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2018
14.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 - 2029
14.3.1. By Treatment Type
14.3.2. By Route of Administration
14.3.3. By Distribution Channel
14.4. Market Attractiveness Analysis
14.4.1. By Treatment Type
14.4.2. By Route of Administration
14.4.3. By Distribution Channel
15. Middle East and Africa Canine Arthritis Treatment Market Analysis 2014-2018 and Forecast 2019-2029
15.1. Introduction
15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2018
15.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 - 2029
15.3.1. By Country
15.3.1.1. GCC Countries
15.3.1.2. South Africa
15.3.1.3. Rest of MEA
15.4. Market Attractiveness Analysis
15.4.1. By Country
15.4.2. By Treatment Type
15.4.3. By Route of Administration
16. Competition Analysis
16.1. Competition Dashboard
16.2. Competition Deep Dive
16.2.1. Elanco (Eli Lily and Company)
16.2.1.1. Overview
16.2.1.2. Product Portfolio
16.2.1.3. Profitability by Market Segments (Product/Route of Administration/Region)
16.2.1.4. Sales Footprint
16.2.1.5. Strategy Overview
16.2.1.5.1. Marketing Strategy
16.2.1.5.2. Product Strategy
16.2.1.5.3. Route of Administration Strategy
16.2.2. Ceva Santé Animale
16.2.2.1. Overview
16.2.2.2. Product Portfolio
16.2.2.3. Profitability by Market Segments (Product/Route of Administration/Region)
16.2.2.4. Sales Footprint
16.2.2.5. Strategy Overview
16.2.2.5.1. Marketing Strategy
16.2.2.5.2. Product Strategy
16.2.2.5.3. Route of Administration Strategy
16.2.3. Vetoquinol S.A
16.2.3.1. Overview
16.2.3.2. Product Portfolio
16.2.3.3. Profitability by Market Segments (Product/Route of Administration/Region)
16.2.3.4. Sales Footprint
16.2.3.5. Strategy Overview
16.2.3.5.1. Marketing Strategy
16.2.3.5.2. Product Strategy
16.2.3.5.3. Route of Administration Strategy
16.2.4. Norbrook Laboratories Limited
16.2.4.1. Overview
16.2.4.2. Product Portfolio
16.2.4.3. Profitability by Market Segments (Product/Route of Administration/Region)
16.2.4.4. Sales Footprint
16.2.4.5. Strategy Overview
16.2.4.5.1. Marketing Strategy
16.2.4.5.2. Product Strategy
16.2.4.5.3. Route of Administration Strategy
16.2.5. Aratana Therapeutics IncMylan Pharmaceuticals Inc.
16.2.5.1. Overview
16.2.5.2. Product Portfolio
16.2.5.3. Profitability by Market Segments (Product/Route of Administration/Region)
16.2.5.4. Sales Footprint
16.2.5.5. Strategy Overview
16.2.5.5.1. Marketing Strategy
16.2.5.5.2. Product Strategy
16.2.5.5.3. Route of Administration Strategy
16.2.6. Boehringer Ingelheim
16.2.6.1. Overview
16.2.6.2. Product Portfolio
16.2.6.3. Profitability by Market Segments (Product/Route of Administration/Region)
16.2.6.4. Sales Footprint
16.2.6.5. Strategy Overview
16.2.6.5.1. Marketing Strategy
16.2.6.5.2. Product Strategy
16.2.6.5.3. Route of Administration Strategy
16.2.7. Zoetis Inc
16.2.7.1. Overview
16.2.7.2. Product Portfolio
16.2.7.3. Profitability by Market Segments (Product/Route of Administration/Region)
16.2.7.4. Sales Footprint
16.2.7.5. Strategy Overview
16.2.7.5.1. Marketing Strategy
16.2.7.5.2. Product Strategy
16.2.7.5.3. Route of Administration Strategy
16.2.8. Bayer AG
16.2.8.1. Overview
16.2.8.2. Product Portfolio
16.2.8.3. Profitability by Market Segments (Product/Route of Administration/Region)
16.2.8.4. Sales Footprint
16.2.8.5. Strategy Overview
16.2.8.5.1. Marketing Strategy
16.2.8.5.2. Product Strategy
16.2.8.5.3. Route of Administration Strategy
16.2.9. VetStem Biopharma
16.2.9.1. Overview
16.2.9.2. Product Portfolio
16.2.9.3. Profitability by Market Segments (Product/Route of Administration/Region)
16.2.9.4. Sales Footprint
16.2.9.5. Strategy Overview
16.2.9.5.1. Marketing Strategy
16.2.9.5.2. Product Strategy
16.2.9.5.3. Route of Administration Strategy
16.2.10. Dechra Pharmaceuticals PLC
16.2.10.1. Overview
16.2.10.2. Product Portfolio
16.2.10.3. Profitability by Market Segments (Product/Route of Administration/Region)
16.2.10.4. Sales Footprint
16.2.10.5. Strategy Overview
16.2.10.5.1. Marketing Strategy
16.2.10.5.2. Product Strategy
16.2.10.5.3. Route of Administration Strategy
17. Assumptions and Acronyms Used
18. Research Methodology

$5,000
$7,500
$10,000

Research Assistance

US: 800.298.5699
Int'l: +1.240.747.3093
Live help
Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Other tasks

Cookie Settings